Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 3 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: Senate
Introduced: May 11, 2026
Last action: Jun 30, 2026 — Substituted by A4852 (ACS)
Session: 222
Momentum: 43 · Moderate

PASSAGE PROBABILITY

3.8% Unlikely

Why this number

Stage base Floor Consideration — base rate 18%, measured from NJ's completed sessions
Momentum -2 43/100 from the pace of recorded action
Time since last action -13 102 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.